Close

Add to pipeline

Save Close
You are viewing a limited version of this profile. To access i3's full capabilities.
Greenlight Biosciences
Save
Company logo (jpg or png)
Parent company
Edit alternate names

Short description

Developer of RNA products for plant and life science applications including vaccines, pandemic preparation, crop management, and plant protection

Founded in 2008
Founded in

Company type Acquired Public ()
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Medford, MA Medford, United States
Address
City
State
Zip
Country

Parent Companies

Website

Updated by Cleantech Group on 03/31/2025

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Add Customer
Date Company
Partnerships
Save
Add Partnership
Date Partner Type
02/25/2014
Bayer CropScience Bayer CropScience
GreenLight Biosciences and Bayer CropScience have formed a partnership to develop GreenLight's technology on agricultural biosciences.
View source    
Confirmed by Bayer CropScience
Development Partner
Delete
Investment Rounds
Save

IPO INFORMATION

Date

02/03/2022

IPO status

Withdrawn

IPO Type

SPAC

Amount

$207M

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

GreenLight Biosciences completed a merger with special purpose acquisition company (SPAC), Environmental Impact Acquisition Corp which rasied $207 million in a January IPO. The deal also includes a $105 million PIPE financing. In 2023, it re-entered the private market through a $46M acquisition deal led by Fall Line Capital

Cancel Save
Add Investment
Date Investors Type Amount
03/26/2025 Just Climate Just Climate (1)
Post-money valuation of
Series C final close includes $25M from Just Climate, though full amount and other investors were not disclosed. Proceeds weill go towards advancing Greenlight's product pipeline and its expansion in South America.
 Growth Equity $25,000,000
Delete
Click to add IPO information
Products
Save
Add Product
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font